Literature DB >> 8547495

USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: introduction. USPHS/IDSA Prevention of Opportunistic Infections Working Group.

J E Kaplan1, H Masur, K K Holmes, M M McNeil, L B Schonberger, T R Navin, D L Hanson, P A Gross, H W Jaffe.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 8547495

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  7 in total

1.  The incidence of cytomegalovirus (CMV) antigenemia and CMV disease is reduced by highly active antiretroviral therapy.

Authors:  S Varani; P Spezzacatena; R Manfredi; F Chiodo; A Mastroianni; P Ballarini; A Boschini; T Lazzarotto; M P Landini
Journal:  Eur J Epidemiol       Date:  2000-05       Impact factor: 8.082

Review 2.  Drug treatment of HIV-related opportunistic infections.

Authors:  M E Klepser; T B Klepser
Journal:  Drugs       Date:  1997-01       Impact factor: 9.546

3.  Prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Updated Guidelines from the Centers for Disease Control and Prevention, National Institutes of Health, and HIV Medicine Association of the Infectious Diseases Society of America.

Authors:  Henry Masur; John T Brooks; Constance A Benson; King K Holmes; Alice K Pau; Jonathan E Kaplan
Journal:  Clin Infect Dis       Date:  2014-02-27       Impact factor: 9.079

Review 4.  Disseminated mycobacterium avium-intracellulare complex (MAC) infection in the era of effective antiretroviral therapy: is prophylaxis still indicated?

Authors:  Christoph G Lange; Ian J Woolley; Reinhard H Brodt
Journal:  Drugs       Date:  2004       Impact factor: 9.546

5.  Are there benefits to starting antiretroviral therapy during primary HIV infection? Conclusions from the Seattle Primary Infection Cohort vary by control group.

Authors:  J D Stekler; R Wellman; S Holte; J Maenza; C E Stevens; L Corey; A C Collier
Journal:  Int J STD AIDS       Date:  2012-03       Impact factor: 1.359

6.  Preparation of the HIV-infected Traveler to the Tropics.

Authors:  Christopher L. Karp
Journal:  Curr Infect Dis Rep       Date:  2001-02       Impact factor: 3.663

Review 7.  Pathogenesis of infections in HIV-infected individuals: insights from primary immunodeficiencies.

Authors:  Qian Zhang; Pierre Frange; Stéphane Blanche; Jean-Laurent Casanova
Journal:  Curr Opin Immunol       Date:  2017-10-06       Impact factor: 7.486
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.